BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 23019192)

  • 1. Tissue remodeling in eosinophilic esophagitis.
    Cheng E; Souza RF; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1175-87. PubMed ID: 23019192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
    Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
    J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remodeling and fibrosis in chronic eosinophil inflammation.
    Aceves SS
    Dig Dis; 2014; 32(1-2):15-21. PubMed ID: 24603375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.
    Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C
    Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin αM activation and upregulation on esophageal eosinophils and periostin-mediated eosinophil survival in eosinophilic esophagitis.
    Vimalathas P; Farris A; Letner D; Deshpande V; Yajnik V; Shreffler W; Garber J
    Immunol Cell Biol; 2018 Apr; 96(4):426-438. PubMed ID: 29424023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE.
    Cheng E; Zhang X; Wilson KS; Wang DH; Park JY; Huo X; Yu C; Zhang Q; Spechler SJ; Souza RF
    PLoS One; 2016; 11(6):e0157376. PubMed ID: 27310888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids.
    Rajan J; Newbury RO; Anilkumar A; Dohil R; Broide DH; Aceves SS
    J Allergy Clin Immunol; 2016 Jan; 137(1):147-156.e8. PubMed ID: 26233926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic role of mast cells in experimental eosinophilic esophagitis.
    Niranjan R; Mavi P; Rayapudi M; Dynda S; Mishra A
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(12):G1087-94. PubMed ID: 23599040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis.
    Rawson R; Yang T; Newbury RO; Aquino M; Doshi A; Bell B; Broide DH; Dohil R; Kurten R; Aceves SS
    J Allergy Clin Immunol; 2016 Sep; 138(3):791-800.e4. PubMed ID: 27212082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.
    Masuda MY; Pyon GC; Luo H; LeSuer WE; Putikova A; Dao A; Ortiz DR; Schulze AR; Fritz N; Kobayashi T; Iijima K; Klein-Szanto AJ; Shimonosono M; Flashner S; Morimoto M; Pai RK; Rank MA; Nakagawa H; Kita H; Wright BL; Doyle AD
    J Allergy Clin Immunol; 2024 May; 153(5):1355-1368. PubMed ID: 38310974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal functional impairments in experimental eosinophilic esophagitis.
    Mavi P; Rajavelu P; Rayapudi M; Paul RJ; Mishra A
    Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1347-55. PubMed ID: 22361731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis.
    Avlas S; Shani G; Rhone N; Itan M; Dolitzky A; Hazut I; Grisaru-Tal S; Gordon Y; Shoda T; Ballaban A; Ben-Baruch NM; Rochman M; Diesendruck Y; Nahary L; Bitton A; Halpern Z; Benhar I; Varol C; Rothenberg ME; Munitz A
    Allergy; 2023 Feb; 78(2):464-476. PubMed ID: 36070083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular immunological mechanisms in eosinophilic esophagitis: an updated overview of their clinical implications.
    Lucendo AJ
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):669-85. PubMed ID: 24742298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
    McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
    Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paired Ig-like Receptor B Inhibits IL-13-Driven Eosinophil Accumulation and Activation in the Esophagus.
    Ben Baruch-Morgenstern N; Mingler MK; Stucke E; Besse JA; Wen T; Reichman H; Munitz A; Rothenberg ME
    J Immunol; 2016 Aug; 197(3):707-14. PubMed ID: 27324131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrotic Effects of the Thiazolidinediones in Eosinophilic Esophagitis Pathologic Remodeling: A Preclinical Evaluation.
    Nhu QM; Hsieh L; Dohil L; Dohil R; Newbury RO; Kurten R; Moawad FJ; Aceves SS
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00164. PubMed ID: 32352681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis.
    Bolton SM; Kagalwalla AF; Arva NC; Wang MY; Amsden K; Melin-Aldana H; Dellon ES; Bryce PJ; Wershil BK; Wechsler JB
    Am J Gastroenterol; 2020 Feb; 115(2):224-233. PubMed ID: 31913192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis.
    Beppu LY; Anilkumar AA; Newbury RO; Dohil R; Broide DH; Aceves SS
    J Allergy Clin Immunol; 2014 Nov; 134(5):1100-1107.e4. PubMed ID: 24835503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.
    Arias Á; Lucendo AJ
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):99-117. PubMed ID: 30791784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over Time.
    Greuter T; Straumann A; Fernandez-Marrero Y; Germic N; Hosseini A; Chanwangpong A; Yousefi S; Simon D; Collins MH; Bussmann C; Chehade M; Dellon ES; Furuta GT; Gonsalves N; Hirano I; Moawad FJ; Biedermann L; Safroneeva E; Schoepfer AM; Simon HU
    Clin Transl Gastroenterol; 2024 Apr; 15(4):e00664. PubMed ID: 38318864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.